Nevertheless, VEGF-C overexpression can now be added to the list of biomarkers such as overexpression of COX-2, Her-2/neu and VEGF-A which indicate poor prognosis in breast cancer patients (Zhang et al, 2003). Here, ERBB2 is linked to breast carcinoma.